Over the last year 23andMe has launched two research initiatives with Pfizer, one to study inflammatory bowel disease and the other to study lupus.
We’re pretty optimistic about the work done so far as we continue to recruit patients to participate in these two important research projects, so it’s nice to see that Pfizer is as excited about the potential as we are.
Pfizer recently posted a video explaining its partnerships more broadly and the company’s hopes for accelerating research. It’s also nice to see 23andMe’s Emily Drabant Conely, our director of business development, featured in one of the videos.
